These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 441526)

  • 21. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P; Trepo C; Brette R; Chevallier P; Vitviski L; Sepetjan M
    Nouv Presse Med; 1981 May; 10(24):1993-6. PubMed ID: 7255135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection.
    Huges-Law G; de Gast GC; Houwen B; The TH; Tegzess AM; van der Hem GK
    Hepatogastroenterology; 1981 Apr; 28(2):93-5. PubMed ID: 7216154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis.
    Jenhani F; Ayed K; Gorgi Y; Zoulim F; Pichoud C; Trepo C
    Ann Trop Med Parasitol; 1990 Aug; 84(4):349-53. PubMed ID: 2260899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B core antigen immune complexes in the liver of hepatitis B patients.
    Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
    Clin Exp Immunol; 1979 Jul; 37(1):15-24. PubMed ID: 385186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease.
    Müller C; Knoflach P; Zielinski CC
    Hepatology; 1989 Dec; 10(6):928-32. PubMed ID: 2583687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymus-derived lymphocytes in type B acute viral hepatitis and healthy carriers of hepatitis B surface antigen (HBsAg).
    Wicks RC; Kohler PF; Singleton JW
    Am J Dig Dis; 1975 Jun; 20(6):518-22. PubMed ID: 1093393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cellular immunity in 18 cirrhotic African carriers of hepatitis B virus surface antigen (HBsAg)].
    Sankale M; Agbetra M
    Bull Soc Pathol Exot Filiales; 1977; 70(4):435-7. PubMed ID: 580921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired interleukin-2 receptor expression on lymphocytes from patients with chronic active hepatitis type B.
    Ahn DS; Jang HC; Ahn JK; Yim CY; Kim DG
    Korean J Intern Med; 1989 Jan; 4(1):34-40. PubMed ID: 2487403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anamnestic response to hepatitis B vaccine in nonalcoholic liver cirrhosis patients with and without HBV-DNA.
    Baruch Y; Enat R; Gershoni-Baruch R; Rimon N; Ben-Porath E
    Am J Gastroenterol; 1992 May; 87(5):613-6. PubMed ID: 1534439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis.
    Gerber MA; Sarno E; Vernace SJ
    N Engl J Med; 1976 Apr; 294(17):922-5. PubMed ID: 768764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-HBc IgM antibodies: prevalence during HB virus infection and value of studying titers].
    Pelletier G; Briantais MJ; Attali P; Buffet C; Pillot J
    Gastroenterol Clin Biol; 1984; 8(8-9):651-5. PubMed ID: 6489685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reactions in acute viral hepatitis.
    Newble DI; Holmes KT; Wangel AG; Forbes IJ
    Clin Exp Immunol; 1975 Apr; 20(1):17-28. PubMed ID: 1204253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis-B-surface-antibodies (detection, incidence, clinical importance)].
    Pesendorfer FX
    Wien Klin Wochenschr Suppl; 1976; 57():1-22. PubMed ID: 1069404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasts in interleukin-1 and interleukin-2 activity in alcoholic hepatitis and cirrhosis.
    Bird GL; Aria KN; Daniels H; Alexander GJ; Williams R
    Alcohol Alcohol; 1989; 24(6):541-6. PubMed ID: 2627242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.
    Thestrup-Pedersen K; Ladefoged K; Andersen P
    Clin Exp Immunol; 1976 Apr; 24(1):1-8. PubMed ID: 949867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
    Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
    Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Behavior of HBs Ag and HBs Ab in chronic hepatitis].
    De Bellis G; Di Martino G; Russo N
    Boll Ist Sieroter Milan; 1976; 55(2):164-7. PubMed ID: 1023884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.